WNT3
Proto-oncogene Wnt-3
Also known as: INT4, MGC131950, MGC138321, MGC138323, WNT3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56703
- Gene
- WNT3
- Ensembl
- ENSG00000108379
- Chromosome
- 17
- Canonical length
- 355 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 98% amino acid identity to mouse Wnt3 protein, and 84% to human WNT3A protein, another WNT gene product. The mouse studies show the requirement of Wnt3 in primary axis formation in the mouse. Studies of the gene expression suggest that this gene may play a key role in some cases of human breast, rectal, lung, and gastric cancer through activation of the WNT-beta-catenin-TCF signaling pathway. This gene is clustered with WNT15, another family member, in the chromosome 17q21 region. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
355 residues, UniProt reviewed canonical sequence.
>P56703|WNT3
1 MEPHLLGLLL GLLLGGTRVL AGYPIWWSLA LGQQYTSLGS QPLLCGSIPG LVPKQLRFCR
61 NYIEIMPSVA EGVKLGIQEC QHQFRGRRWN CTTIDDSLAI FGPVLDKATR ESAFVHAIAS
121 AGVAFAVTRS CAEGTSTICG CDSHHKGPPG EGWKWGGCSE DADFGVLVSR EFADARENRP
181 DARSAMNKHN NEAGRTTILD HMHLKCKCHG LSGSCEVKTC WWAQPDFRAI GDFLKDKYDS
241 ASEMVVEKHR ESRGWVETLR AKYSLFKPPT ERDLVYYENS PNFCEPNPET GSFGTRDRTC
301 NVTSHGIDGC DLLCCGRGHN TRTEKRKEKC HCIFHWCCYV SCQECIRIYD VHTCKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against WNT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- skin: 27 nTPM
- liver: 12 nTPM
- testis: 4.3 nTPM
- hypothalamus: 4 nTPM
- parathyroid gland: 4 nTPM
- cerebral cortex: 3.2 nTPM
Single-cell type
- late spermatids: 59 nCPM
- bergmann glia: 58 nCPM
- early spermatids: 22 nCPM
- podocytes: 15 nCPM
- basal keratinocytes: 12 nCPM
- astrocytes: 10 nCPM
Immune cell
- T-reg: 0.3 nTPM
- naive B-cell: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- memory B-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- thalamus: 10 nTPM
- hypothalamus: 4.5 nTPM
- midbrain: 4.4 nTPM
- pons: 3.7 nTPM
- cerebral cortex: 3.4 nTPM
- medulla oblongata: 3.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about WNT3.
Disease | AllUniProt
Conditions WNT3 is implicated in, by any mechanism.
- Tetraamelia syndrome 1 (TETAMS1) MIM:273395
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 147 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Tetraamelia syndrome 1
- Bladder exstrophy-epispadias-cloacal exstrophy complex
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.88
- gnomAD missense Z
- 3.18
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior axis specification
- axon guidance
- canonical Wnt signaling pathway
- cell fate commitment
- cell morphogenesis
- cellular response to retinoic acid
- dorsal/ventral axis specification
- embryonic forelimb morphogenesis
- embryonic hindlimb morphogenesis
- gamete generation
- gene expression
- head morphogenesis
- limb bud formation
- mammary gland epithelium development
- mesoderm formation
- midbrain dopaminergic neuron differentiation
- negative regulation of axon extension involved in axon guidance
- neuron differentiation
- positive regulation of collateral sprouting in absence of injury
- positive regulation of gene expression
- positive regulation of osteoblast differentiation
- positive regulation of Wnt signaling pathway
- regulation of mesenchymal stem cell differentiation
- regulation of neurogenesis
- stem cell proliferation
- Spemann organizer formation at the anterior end of the primitive streak
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of WNT3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads WNT3 as an antibody target. Whether an autoantibody or antibody against WNT3 could matter depends on whether native WNT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
WNT3 is annotated as secreted, so native WNT3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label WNT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...